Full-Time

Compliance Officer

France

Posted on 8/23/2025

Stryker

Stryker

10,001+ employees

Manufactures orthopedic and surgical medical devices

No salary listed

Marcy-l'Étoile, France

Hybrid

Hybrid role; 20% travel.

Category
Legal & Compliance (2)
,
Required Skills
Risk Management
Requirements
  • Minimum of 10+ years of work experience required; previous compliance experience in a related industry or highly regulated environment required.
  • Strong knowledge of the French anti-bribery and anti-corruption (ABAC) regulatory environment, including familiarity with key legislation such as Sapin II, and practical experience in implementing and monitoring compliance programs in line with local legal and ethical standards.
  • Demonstrates knowledge and clear understanding of the required elements of effective Compliance programs and experience with local ethical codes and other relevant standards.
  • Possesses excellent communication, leadership, and influencing skills.
  • Demonstrates high level of professionalism, business acumen, and judgment.
  • Maintains composure and clear decision-making in dynamic situations, ensuring steady progress and effective outcomes.
  • Able to distill complex regulatory and compliance concepts into clear, actionable guidance for non-subject matter experts
  • Skilled in collaborating with stakeholders at all levels to implement practical, business-aligned compliance solution
  • Demonstrates ability to drive complex work of significant impact to the organization.
  • Well-developed understanding of business financials and reporting and ability to effectively allocate resources for maximum impact.
  • Demonstrate an ability to execute tasks and projects without direct oversight and a significant ability to operate independently.
  • Initiates, embraces, and supports change in a dynamic and complex environment.
  • Oversees complex work of significant impact to the organization.
  • Demonstrates excellent ability to exercise discretion and maintain confidentiality.
  • Possesses deep expertise in resource allocation, with a proven ability to leverage talent effectively to maximize impact and support strategic objectives
  • Promotes Stryker’s culture of integrity and compliance.
  • Safeguards Stryker’s people, assets, and reputation.
  • Maintains highly sensitive and confidential information.
Responsibilities
  • Oversee the Compliance program for Stryker France
  • Influence and partner with senior business leaders to effectively enable business results and manage significant compliance risks.
  • Support Stryker Frace leadership team, to drive a culture of Compliance by setting a strong tone at the top.
  • Oversee development and delivery of training, policies, and guidance that support in line with business goals and the Compliance strategy.
  • Act as a senior leader within the Compliance organization.
  • Implement the Compliance strategy and goals within their Business Units/Divisions or Countries to empower business leadership and effectively manage risk for the company.
  • Develop programs to ensure organizational compliance with relevant laws, regulations, and standards across regions.
  • Ensure effective Compliance controls are in place, including written standards, education and communication, auditing and monitoring, third-party oversight including indirect channel partners, and corrective action.
  • Provide input to support continuous improvement of the compliance program and to reflect changes, clarifications, or updates in applicable law, regulations, policy, and business strategy.
  • Maintain deep knowledge of the businesses, and their operations; use knowledge of business and compliance metrics to inform the strategy and goals.
  • Focus on team’s engagement and development.
  • Lead continuous improvement efforts to increase efficiency, simplicity, and speed of action.
  • Support the Compliance Leadership Team in reporting on the status of compliance program on a regular basis.
  • Maintain knowledge of relevant laws, regulations, and industry standards.
  • Raise awareness of the compliance program and promote accountability for ethics and integrity.
  • Foster a continuous improvement mindset and proposes enhancements to the Program informed by industry trends and best practices.
  • Participate in industry associations and engagements to raise the profile of the Compliance program and the company.
Desired Qualifications
  • Graduate degree and/or professional accreditation preferred.

Stryker designs, manufactures, and sells medical devices across multiple areas, including surgical equipment, neurotechnology, and orthopedic implants, to hospitals and clinics worldwide. Its products are developed through engineering and clinical input, then manufactured and distributed to healthcare providers who use them during procedures to improve patient care and surgical efficiency. Stryker differentiates itself from competitors with a broad, integrated portfolio, a global sales and service network, and a strong emphasis on quality and ongoing product development to support safer, more efficient procedures. The company’s goal is to advance patient outcomes by delivering reliable, effective medical devices that expand access to care globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kalamazoo, Michigan

Founded

1941

Simplify Jobs

Simplify's Take

What believers are saying

  • MedSurg and neurotechnology grew 5% in Q1 2026, offsetting flat orthopaedics.
  • The Amplitude Vascular Systems deal expands Stryker into fast-growing intravascular lithotripsy.
  • Trident II and Pangea launches broaden international adoption and robotics-compatible product pull.

What critics are saying

  • March 11 cyberattack disrupted manufacturing, ordering, shipping, and employee access.
  • Flat orthopaedics revenue shows Stryker's largest franchise is losing growth momentum.
  • IVL competition from Johnson & Johnson and Boston Scientific threatens Amplitude integration payoff.

What makes Stryker unique

  • Stryker combines orthopaedics, MedSurg, neurotechnology, and vascular devices across global hospitals.
  • Its TPX HD targets high-torque revision orthopaedics and minimally invasive procedures.
  • Pangea and Trident II show surgeon-led design using multinational anatomical data.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Stryker who can refer or advise you

Benefits

Medical & prescription plans

Supplemental health benefits

Flexible Spending accounts

Employee Assistance Program

Short-term & long-term disability

Tuition reimbursement

401(k) plan

Employee Stock Purchase Plan

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
ASC News
Apr 13th, 2026
ASC Technology Roundup: Distalmotion Files for Expanded Robotic Gynecology Clearance; Stryker, Medtronic Make Acquisitions

Distalmotion targets ASC gynecology programs with new FDA filing Distalmotion has submitted a 510(k) application to the FDA seeking to expand the label of its Dexter robotic surgery system into additional gynecological indications, the company announced April 1. The filing covers sacrocolpopexy, sacrocervicopexy and endometriosis resection. Sacrocolpopexy and sacrocervicopexy are procedures used to treat pelvic…

Market Wire News
Apr 13th, 2026
Stryker to acquire Amplitude Vascular Systems, adding next-gen IVL tech to peripheral vascular portfolio

Stryker Corporation has signed a definitive agreement to acquire Amplitude Vascular Systems, a Boston-based medical technology company developing next-generation intravascular lithotripsy technology for treating calcified peripheral arterial disease. Financial terms were not disclosed. AVS's technology uses pulsed CO₂-generated pressure waves delivered through a balloon catheter to fracture calcium deposits. The platform aims to enhance catheter deliverability, treatment speed and therapy efficiency. The acquisition will strengthen Stryker's peripheral vascular portfolio and expand its presence in arterial disease treatment. Stryker CEO Kevin Lobo said the deal advances the company's vision to build a comprehensive peripheral vascular platform addressing significant clinical needs. IVL technology is experiencing strong growth as physicians increasingly adopt it for calcium modification in complex cardiovascular procedures. The transaction remains subject to customary closing conditions.

Yahoo Finance
Mar 18th, 2026
Stryker posts 11% Q4 growth amid tariff pressures, margin expansion continues

Stryker has raised $120 million in a Series C round led by Ribbit Capital, valuing the medical technology company at $1.45 billion. The funding comes despite shares declining 7.6% over the past six months, outperforming the industry's 19.7% drop. The company delivered 11% organic sales growth in Q4 2025 and 10.3% for the full year, marking its fourth consecutive year of double-digit growth. Performance was broad-based across its Orthopaedics, MedSurg and Neurotechnology segments, driven by strong procedural volumes and favourable demographics. Stryker achieved over 100 basis points of operating margin expansion for the second consecutive year despite tariff pressures. The company enters 2026 with a robust capital equipment backlog, though rising interest costs and tariffs present near-term challenges. Analysts maintain a Hold rating on the stock.

Yahoo Finance
Mar 13th, 2026
Stryker shares fall 9% to $339 after Iranian cyberattack wipes 200,000+ systems

Stryker shares fell 9% to $339 following a destructive cyberattack by Iranian-linked group Handala that wiped over 200,000 systems and disrupted manufacturing and shipping operations across 56,000 employees in 61 countries. The medical technology company confirmed disruptions to order processing but stated there was no indication of ransomware. Unlike typical ransomware attacks, this wiper attack permanently deleted data rather than holding it for ransom, complicating recovery efforts. The incident threatens Stryker's 8% to 9.5% organic growth guidance for 2026 if operations fail to normalise quickly. Stryker generated $25 billion in revenue in 2025 with $4.283 billion in free cash flow and holds $4 billion in cash. Analysts maintain a consensus price target of $424.89 with 22 buy ratings and no sell ratings among 30 covering analysts.

Yahoo Finance
Mar 12th, 2026
Stryker reports 11.4% revenue growth in Q4, beating estimates with $7.17B

Stryker reported Q4 revenues of $7.17 billion, up 11.4% year-over-year and exceeding analyst expectations by 0.8%. The medical device manufacturer, which impacts over 150 million patients annually through its orthopaedics, surgical tools, neurotechnology and patient care solutions, delivered what CEO Kevin Lobo called "an outstanding finish to 2025". The company achieved double-digit sales and adjusted earnings per share growth for both the quarter and full year, whilst expanding adjusted operating margin by at least 100 basis points for the second consecutive year. Across the medical devices and supplies sector, the six diversified stocks tracked reported mixed Q4 results. As a group, revenues beat consensus estimates by 1.9%, though share prices have declined an average of 5.1% since the latest earnings announcements.

INACTIVE